169 related articles for article (PubMed ID: 25078640)
1. Clinical course and characterisation of lymphangioleiomyomatosis in a Brazilian reference centre.
Baldi BG; Freitas CS; Araujo MS; Dias OM; Pereira DA; Pimenta SP; Kairalla RA; Carvalho CR
Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):129-35. PubMed ID: 25078640
[TBL] [Abstract][Full Text] [Related]
2. Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis.
Baldi BG; Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
Am J Respir Crit Care Med; 2012 Aug; 186(4):341-8. PubMed ID: 22700863
[TBL] [Abstract][Full Text] [Related]
3. COPD assessment test as a possible tool for evaluating health-related quality of life in lymphangioleiomyomatosis.
Kato M; Kanehiro Y; Yoshimi K; Kodama Y; Sekiya M; Sato T; Takahashi K; Seyama K;
Respir Investig; 2018 Nov; 56(6):480-488. PubMed ID: 30143460
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary function test results are correlated with 6-minute walk distance, distance-saturation product, and 6-minute walk work in patients with lymphangioleiomyomatosis.
Diesler R; Cottin V; Gallien Y; Turquier S; Traclet J; Ahmad K; Glerant JC
Respir Med Res; 2024 Jun; 85():101071. PubMed ID: 38141576
[TBL] [Abstract][Full Text] [Related]
5. A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis.
Chang WY; Cane JL; Kumaran M; Lewis S; Tattersfield AE; Johnson SR
Eur Respir J; 2014 Apr; 43(4):1114-23. PubMed ID: 24311763
[TBL] [Abstract][Full Text] [Related]
6. Sleep desaturation and its relationship to lung function, exercise and quality of life in LAM.
Medeiros P; Lorenzi-Filho G; Pimenta SP; Kairalla RA; Carvalho CR
Respir Med; 2012 Mar; 106(3):420-8. PubMed ID: 22217496
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal follow-up study of 11 patients with pulmonary lymphangioleiomyomatosis: diverse clinical courses of LAM allow some patients to be treated without anti-hormone therapy.
Seyama K; Kira S; Takahashi H; Ohnishi M; Kodama Y; Dambara T; Kobayashi J; Kitamura S; Fukuchi Y
Respirology; 2001 Dec; 6(4):331-40. PubMed ID: 11844125
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
[TBL] [Abstract][Full Text] [Related]
9. A pilot study assessing the effect of bronchodilator on dynamic hyperinflation in LAM.
Baldi BG; de Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
Respir Med; 2013 Nov; 107(11):1773-80. PubMed ID: 24064347
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serum vascular endothelial growth factor-D concentration with clinical presentation and course of lymphangioleiomyomatosis.
Radzikowska E; Jaguś P; Sobiecka M; Chorostowska-Wynimko J; Wiatr E; Kuś J; Roszkowski-Śliż K
Respir Med; 2015 Nov; 109(11):1469-75. PubMed ID: 26386638
[TBL] [Abstract][Full Text] [Related]
11. Concentration of Serum Vascular Endothelial Growth Factor (VEGF-D) and Its Correlation with Functional and Clinical Parameters in Patients with Lymphangioleiomyomatosis from a Brazilian Reference Center.
Amaral AF; de Oliveira MR; Dias OM; Arimura FE; Freitas CSG; Acencio MMP; de Alvarenga VA; Kairalla RA; Carvalho CRR; Baldi BG;
Lung; 2019 Apr; 197(2):139-146. PubMed ID: 30623243
[TBL] [Abstract][Full Text] [Related]
12. Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone.
Taveira-DaSilva AM; Stylianou MP; Hedin CJ; Hathaway O; Moss J
Chest; 2004 Dec; 126(6):1867-74. PubMed ID: 15596686
[TBL] [Abstract][Full Text] [Related]
13. Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
Neurohr C; Hoffmann AL; Huppmann P; Herrera VA; Ihle F; Leuschner S; von Wulffen W; Meis T; Baezner C; Leuchte H; Baumgartner R; Zimmermann G; Behr J
Respir Res; 2011 May; 12(1):66. PubMed ID: 21600034
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial.
Araujo MS; Baldi BG; Freitas CS; Albuquerque AL; Marques da Silva CC; Kairalla RA; Carvalho CR; Carvalho CR
Eur Respir J; 2016 May; 47(5):1452-60. PubMed ID: 26917604
[TBL] [Abstract][Full Text] [Related]
15. Patients' perceptions versus medical testing of function in women with lymphangioleiomyomatosis (LAM).
Pollock-BarZiv SM; Cohen MM; Maclean H; Downey GP
Respir Med; 2005 Jul; 99(7):901-9. PubMed ID: 15939253
[TBL] [Abstract][Full Text] [Related]
16. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects.
Chetta A; Pisi G; Zanini A; Foresi A; Grzincich GL; Aiello M; Battistini A; Olivieri D
Respir Med; 2001 Dec; 95(12):986-91. PubMed ID: 11778797
[TBL] [Abstract][Full Text] [Related]
17. The NHLBI LAM Registry: Prognostic Physiologic and Radiologic Biomarkers Emerge From a 15-Year Prospective Longitudinal Analysis.
Gupta N; Lee HS; Ryu JH; Taveira-DaSilva AM; Beck GJ; Lee JC; McCarthy K; Finlay GA; Brown KK; Ruoss SJ; Avila NA; Moss J; McCormack FX;
Chest; 2019 Feb; 155(2):288-296. PubMed ID: 29940164
[TBL] [Abstract][Full Text] [Related]
18. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD).
Fujimoto H; Asai K; Watanabe T; Kanazawa H; Hirata K
Osaka City Med J; 2011 Jun; 57(1):21-9. PubMed ID: 22106764
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis.
Seyama K; Kumasaka T; Souma S; Sato T; Kurihara M; Mitani K; Tominaga S; Fukuchi Y
Lymphat Res Biol; 2006; 4(3):143-52. PubMed ID: 17034294
[TBL] [Abstract][Full Text] [Related]
20. Emerging clinical picture of lymphangioleiomyomatosis.
Cohen MM; Pollock-BarZiv S; Johnson SR
Thorax; 2005 Oct; 60(10):875-9. PubMed ID: 16055626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
